biosig_rgb.png
BioSig Regains Compliance With All Nasdaq Listing Standards
February 22, 2023 07:30 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 22, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig Awarded US Patent Claims for its Universal Notch Filter Technology
February 17, 2023 07:30 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Patent can remove any fixed frequency interfering with original signal of interest preserving critical intracardiac dataBioSig now has 56 worldwide...
WellSpan York Hospital live case demonstration
WellSpan York Hospital Hosts Female Interventional Cardiologists From Across The Globe For Women’s Heart Health Leadership Event
February 09, 2023 14:58 ET | WellSpan Health
York, Pa., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Top female doctors joined WellSpan’s Dr. Rhian Davies in York earlier today to discuss women’s heart health and participate in three live case...
biosig_rgb.png
BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy
February 07, 2023 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Chief Financial Officer Steve Chaussy retires following 12 years of serviceSteve Buhaly joins BioSig as CFOBuhaly brings 15 years of public company...
Color Logo.png
Structural Heart Devices Market will grow to USD 31.7 billion by 2030 : GreyViews
January 27, 2023 15:00 ET | GreyViews
Pune India, Jan. 27, 2023 (GLOBE NEWSWIRE) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle...
biosig_rgb.png
BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments
January 19, 2023 08:30 ET | BioSig Technologies, Inc.
Westport, CT, Jan. 19, 2023 (GLOBE NEWSWIRE) -- To date, the Company's FDA 510(k)-cleared PURE EP™ System has been used in approximately 3,000 patient cases across the United States The...
biosig_rgb.png
Update: BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
December 14, 2022 16:30 ET | BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- - BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
biosig_rgb.png
BioSig’s PURE EP™ System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore
December 14, 2022 08:00 ET | BioSig Technologies, Inc.
Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering...
avicorelogo.png
Avricore Health Reports Third-Quarter 2022 Results
November 29, 2022 11:08 ET | Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth,...
InCarda Logo.png
Final Results from Phase 2 INSTANT Trial of InRhythm™ for the Treatment of Newly Diagnosed and Recurrent Paroxysmal Atrial Fibrillation Presented at 2022 American Heart Association Scientific Sessions
November 07, 2022 07:00 ET | InCarda Therapeutics, Inc.
Data Demonstrate Orally Inhaled Flecainide May Provide a Safe, Effective, and Convenient First-Line Treatment Option for Cardioversion of Recent-Onset Newly Diagnosed and Paroxysmal Atrial...